RxDoctor Payments Data

Ryan Donovan, PA

Medical · New Haven, CTNPI 1881650364

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Philips North America LLC accounts for 99.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $30,509, 5.0 times the $6,104 reported in 2021. Among medical clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,736in general payments, 2019–2025

Across 200 payments — averaging $373.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$74K
  • Impulse Dynamics (USA) Inc.$294
  • Medtronic$163
  • Atricure, Inc.$17
  • Cardiva Medical, Inc.$16

What the payments were for

  • Consulting fees$36,28349%
  • Speaking & faculty fees$12,59517%
  • Travel & lodging$22,95131%
  • Food & beverage$2,9074%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,736 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.

See all medical providers in Connecticut

Medicare billing

Part B allowed, 2024
$79,399
Medicare patients
752
Services billed
2,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban346$494,035
XareltoRivaroxaban127$169,536
Dofetilide20$6,272
Flecainide Acetate82$4,067
Metoprolol Succinate243$3,713
Dabigatran EtexilateDabigatran Etexilate Mesylate11$3,414
SotalolSotalol Hcl83$2,590
Amiodarone Hcl94$1,866
Mexiletine Hcl15$1,793
Diltiazem 24hr Er (Cd)Diltiazem Hcl45$1,533
Atorvastatin Calcium33$568
Metoprolol Tartrate63$529
Amlodipine Besylate38$406
Carvedilol29$380
Lisinopril29$344

Paid to pharmacies, not to this prescriber.

Other medical in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →